Cochrane Review: Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)
Authors:
- 6 September 2012
- journal article
- review article
- Published by Wiley in Evidence-Based Child Health: A Cochrane Review Journal
- Vol. 7 (5) , 1719-1790
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Systematic review of influenza resistance to the neuraminidase inhibitorsBMC Infectious Diseases, 2011
- Clinical prediction rules combining signs, symptoms and epidemiological context to distinguish influenza from influenza-like illnesses in primary care: a cross sectional studyBMC Family Practice, 2011
- PAI-1 Expression Is Required for HDACi-Induced Proliferative Arrest inras-Transformed Renal Epithelial CellsInternational Journal of Cell Biology, 2011
- Efficacy and Safety of Intravenous Peramivir for Treatment of Seasonal Influenza Virus InfectionAntimicrobial Agents and Chemotherapy, 2010
- Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009BMC Infectious Diseases, 2010
- Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate (CS-8958) versus Oseltamivir as Treatment for Children with Influenza Virus InfectionAntimicrobial Agents and Chemotherapy, 2010
- Relative Impact of Influenza and Respiratory Syncytial Virus in Young ChildrenPediatrics, 2009
- CS-8958, a Prodrug of the New Neuraminidase Inhibitor R-125489, Shows Long-Acting Anti-Influenza Virus ActivityAntimicrobial Agents and Chemotherapy, 2009
- Pharmacokinetics and Tolerability of Oseltamivir Combined with ProbenecidAntimicrobial Agents and Chemotherapy, 2008
- OseltamivirDrugs, 1999